Abiopharma

🔍 Spaulding Dan (Executive)

Company: ZILLOW GROUP, INC. (Z AND ZG)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 1,966 shares of Class C Capital Stock at $34.2444 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 47,730.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,169 shares of Class C Capital Stock at $35.3692 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,561.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents shares sold to cover tax withholding due upon vesting of restricted stock units.
• F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.16 to $34.48. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
• F3: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.3436 to $35.37. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.